Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Dec;261(12):3355-3367.
doi: 10.1007/s00417-023-06083-4. Epub 2023 May 10.

Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials

Xiaonan Sun  1 , Lei Liu  1 , Chi Liu  2
Affiliations
Meta-Analysis

Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials

Xiaonan Sun et al. Graefes Arch Clin Exp Ophthalmol. 2023 Dec.

Abstract

Background: Diquafosol enhances fluid transfer and mucin secretion on ocular surface, which has been suggested as an effective treatment for dry eye disease (DED). The aim of the systematic review and meta-analysis was to compare the efficacy and safety of topical diquafosol versus hyaluronic acid (HA) for DED.

Methods: Relevant randomized controlled trials were obtained via search of electronic including PubMed, Embase, Cochrane Library, and Web of Science. A random-effects model was used to pool the results after incorporating the influence of potential heterogeneity.

Results: A total of nine RCTs involving 1295 patients with DED were included in the meta-analysis. Compared to treatment with 0.1% HA, topical treatment with 3% diquafosol significantly improved the Ocular Surface Disease Index (mean difference (MD): - 3.59, 95% confidence interval (CI): - 4.68 to - 2.50, p < 0.001; I2 = 6%), results of Schirmer's test (MD: 1.08 mm, 95% CI: 0.41 to 1.76, p = 0.002; I2 = 0%), tear breakup time (MD: 0.60 s, 95% CI: 0.20 to 0.99, p = 0.003; I2 = 63%), corneal fluorescein staining score (MD: - 0.20, 95% CI: - 0.37 to - 0.03, p = 0.02; I2 = 58%), and ocular rose bengal staining score (MD: - 0.62, 95% CI: - 0.88 to - 0.35, p < 0.001; I2 = 15%). No severe adverse events were reported. Topical use of diquafosol was associated with a higher risk of overall adverse events as compared to HA (odds ratio: 1.71, 95% CI: 1.08 to 2.71, p = 0.02; I2 = 18%).

Conclusions: Topical treatment with 3% diquafosol may be more effective than 0.1% HA for patients with DED. However, the long-term efficacy and tolerability of diquafosol still need to be determined.

Keywords: Diquafosol; Dry eye disease; Efficacy; Hyaluronic acid; Meta-analysis.

PubMed Disclaimer

References

    1. Cai Y, Wei J, Zhou J, Zou W (2022) Prevalence and incidence of dry eye disease in Asia: a systematic review and meta-analysis. Ophthalmic Res 65:647–658. https://doi.org/10.1159/000525696000525696 - DOI - PubMed
    1. Qian L, Wei W (2022) Identified risk factors for dry eye syndrome: a systematic review and meta-analysis. PloS One 17:e0271267. https://doi.org/10.1371/journal.pone.0271267 - DOI - PubMed - PMC
    1. Fjaervoll K, Fjaervoll H, Magno M, Noland ST, Dartt DA, Vehof J, Utheim TP (2022) Review on the possible pathophysiological mechanisms underlying visual display terminal-associated dry eye disease. Acta Ophthalmol 100:861–877. https://doi.org/10.1111/aos.15150AOS15150 - DOI - PubMed - PMC
    1. Sekhon AS, He B, Iovieno A, Yeung SN (2021) Pathophysiology of corneal endothelial cell loss in dry eye disease and other inflammatory ocular disorders. Ocul Immunol Inflamm 1-11. https://doi.org/10.1080/09273948.2021.1980808
    1. Basilious A, Xu CY, Malvankar-Mehta MS (2022) Dry eye disease and psychiatric disorders: a systematic review and meta-analysis. Eur J Ophthalmol 32:1872–1889. https://doi.org/10.1177/11206721211060963 - DOI - PubMed

LinkOut - more resources